Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
2.070
-0.030 (-1.43%)
Dec 20, 2024, 4:00 PM EST - Market closed
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $3.08 million as of December 20, 2024. Its market cap has increased by 100.99% in one year.
Market Cap
3.08M
Enterprise Value
-1.70M
1-Year Change
100.99%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $3.08M, a decrease of -92.53%. That is a compound annual growth rate of -58.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 3.08M | 139.30% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alaunos Therapeutics | 3.23M |
| Aditxt | 3.22M |
| Theriva Biologics | 3.20M |
| ReShape Lifesciences | 3.19M |
| Petros Pharmaceuticals | 3.13M |
| iCoreConnect | 3.12M |
| Lipella Pharmaceuticals | 3.11M |
| Processa Pharmaceuticals | 3.08M |